Chemistry of Ecteinascidins. Part 4: Preparation of 2′-<i>N</i>-Acyl Ecteinascidin 770 Derivatives with Improved Cytotoxicity Profiles
-
- Tsujimoto Mitsuhiro
- Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University
-
- Lowtangkitcharoen Witaya
- Center for Bioactive Natural Products from Marine Organisms and Endophytic Fungi (BNPME), Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University
-
- Mori Nanae
- Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University
-
- Pangkruang Waree
- Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University
-
- Putongking Ploenthip
- Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Khon Kaen University
-
- Suwanborirux Khanit
- Center for Bioactive Natural Products from Marine Organisms and Endophytic Fungi (BNPME), Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University
-
- Saito Naoki
- Graduate School of Pharmaceutical Sciences, Meiji Pharmaceutical University
Bibliographic Information
- Other Title
-
- Chemistry of Ecteinascidins(Part 4)Preparation of 2'-N-Acyl Ecteinascidin 770 Derivatives with Improved Cytotoxicity Profiles
Search this article
Abstract
We report herein eleven 2′-N-acyl derivatives that were prepared from ecteinascidin 770 (Et 770: 1b) via 18,6′-O-bisallyl protected compound (4) in excellent yields. 2′-N-Acyl derivatives (6a–k) generally showed higher cytotoxicity than 1b. Among them, 3-quinolineacyl derivative (6g) and 4-fluorocinnamoyl derivative (6h) exhibited approximately 50- and 70-fold higher cytotoxicity to the HCT116 human colon carcinoma cell line, respectively, than 1b. Both compounds are potent inhibitors of the in vitro growth of several tumor cells and are therefore promising leads for further optimization. We also report the transformation of 1b into Et 788 (3), which is the first example of an ecteinascidin derivative having a primary amide at C-21 position.
Journal
-
- Chemical and Pharmaceutical Bulletin
-
Chemical and Pharmaceutical Bulletin 61 (10), 1052-1064, 2013
The Pharmaceutical Society of Japan
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204177296640
-
- NII Article ID
- 130004137252
-
- NII Book ID
- AA00602100
-
- COI
- 1:STN:280:DC%2BC2c%2FlvVeisA%3D%3D
-
- ISSN
- 13475223
- 00092363
-
- NDL BIB ID
- 024872905
-
- PubMed
- 24088697
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
-
- Abstract License Flag
- Disallowed